Cynata Therapeutics Ltd has released a press release.
Ethics Approval for Cynatas Clinical Trial in DFU
Filed with ASX ·
6ix hasn’t read this filing yet.
Cynata Therapeutics Limited on 6ix
Earlier from Cynata Therapeutics
- Progress Toward Clinical Trial in Diabetic Foot Ulcers
- Cynata signs Licence Agreement with TekCyte
- First Patient Enrolled in Cynata MEND Clinical Trial
- Cynata Therapeutics Expands MEND clinical trial in COVID-19 and Respiratory Failure
- Cynata Expands trial in COVID-19 & Respiratory Failure
Later from Cynata Therapeutics
- Cynata Receives Notice of Allowance from US Patent Office
- Further Canadian Patent for Cynata
- Further Patents for Cynata Unique Cymerus Technology
- Cynata Enters into a New Strategic Partnership with Fujifilm
- DSMB Recommends Continuation of Cynatas MEND Trial
Follow Cynata Therapeutics into a list and get an email when it puts out news.
Follow Cynata Therapeutics